Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
06/02/20248:38PMGlobeNewswire Inc.Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pembrolizumab) in Pivotal Phase III TrialNASDAQ:IMMPImmutep Ltd
06/02/20248:38PMGlobeNewswire Inc.Immutep Announces Clinical Collaboration with MSD to Evaluate Efti in Combination with KEYTRUDA® (pembrolizumab) in Pivotal Phase III TrialIMM.AX
06/02/20248:35PMBusiness WireWEBTOON Entertainment Announces Public Filing of Registration Statement for Proposed Initial Public Offering
06/02/20248:23PMGlobeNewswire Inc.Mesoblast Corporate Presentation at Investor ConferenceMSB.AX
06/02/20248:23PMGlobeNewswire Inc.Mesoblast Corporate Presentation at Investor ConferenceNASDAQ:MESOMesoblast Limited
06/02/20248:20PMBusiness WireDenodo ouvre un siège régional en Arabie saoudite pour répondre à la demande croissante en matière de gestion des données et d'intelligence artificielle
06/02/20248:15PMBusiness WireDenodo eröffnet im Königreich Saudi Arabien ME Regionalen Hauptsitz zwecks Abdeckung der steigenden Nachfrage nach Datenmanagement und KI
06/02/20248:00PMGlobeNewswire Inc.HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature MedicineNASDAQ:HCMHUTCHMED China Limited
06/02/20248:00PMPR Newswire (US)Darren Bishop Joins TradeFlow Capital Management as Head of Strategic Partnerships (UK/Europe)
06/02/20247:54PMPR Newswire (US)BLVD United Signs MOU with MeDoDo Coin: Pioneering a New Era in Fan Engagement and Biotech Innovation
06/02/20247:46PMBusiness WireDenodo integriert NVIDIA NIM Inference Microservices für die Beschleunigung und Optimierung von KI-Funktionen für Unternehmen
06/02/20247:39PMBusiness WireDenodo intègre les microservices d'inférence NIM de NVIDIA pour accélérer et optimiser les capacités d'IA pour les entreprises
06/02/20247:00PMBusiness WireOther World Computing Introduces Intel Thunderbolt Share for the Thunderbolt Go Dock
06/02/20247:00PMGlobeNewswire Inc.Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CRBUCaribou Biosciences Inc
06/02/20247:00PMPR Newswire (US)Cody Allison Named Mid-South Super Lawyer Again; Featured Attorney in Mid-South Super Lawyers Magazine
06/02/20246:54PMPR Newswire (US)William David Art Gallery Opens in Las Vegas with Captivating Collections: The Royal Family and Serial Killers
06/02/20246:54PMPR Newswire (Canada)La Chine et la Corée du Sud renforcent leurs liens économiques à l'occasion de la conférence promotionnelle de la deuxième édition de la CISCE
06/02/20246:43PMGlobeNewswire Inc.Telix Completes TLX250-CDx (Zircaix™) BLA Submission for Kidney Cancer ImagingTLX.AX
06/02/20246:20PMGlobeNewswire Inc.Biognosys lanza Spectronaut 19 y presenta los avances de sus plataformas de investigación en la Conferencia Anual de la ASMS 2024
06/02/20246:20PMGlobeNewswire Inc.Biognosys lance Spectronaut 19 et présente les avancées dans ses plateformes de recherche lors de la conférence annuelle de l’ASMS 2024
06/02/20246:20PMGlobeNewswire Inc.Biognosys bringt Spectronaut 19 auf den Markt und präsentiert die Fortschritte seiner Forschungsplattformen auf der Jahreskonferenz der ASMS 2024
06/02/20246:20PMGlobeNewswire Inc.Biognosys lancia Spectronaut 19 e presenta i progressi delle sue piattaforme di ricerca alla conferenza annuale ASMS 2024
06/02/20246:15PMPR Newswire (US)Fast Guard Service Shares Their Experience with Local Business Owner as the Best Security Guard Company in California
06/02/20246:01PMPR Newswire (US)One in Five European Companies Are Facing Strong Pressure to Transform to Stay Viable
06/02/20246:00PMBusiness WireNew Blood Test Predicts Recurrence of Breast Cancer, Months or Even Years Before Relapse
06/02/20245:30PMBusiness WirePreliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular LymphomaNASDAQ:GMABGenmab AS
06/02/20245:30PMGlobeNewswire Inc.Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular LymphomaTG:GE9Genmab AS
06/02/20245:29PMPR Newswire (Canada)Bilan du Festival Go vélo Montréal 2024 - Une semaine parfaite pour (re)découvrir Montréal à vélo!
06/02/20245:28PMGlobeNewswire Inc.Le congrès de l’EAACI débute à Valence, en Espagne
06/02/20245:28PMGlobeNewswire Inc.Começa o Congresso da EAACI em Valência, Espanha

Your Recent History

Delayed Upgrade Clock